Declan Doogan, Director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 20,796 shares at $44.31 ($921K) on 2019-02-26, disclosed to the SEC on 2019-02-26.
Open-market sale of $921k BHVN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BHVN | SELL | 2022-02-11 | $5.0M | — | Filing → |
| BHVN | SELL | 2021-12-01 | $5.5M | — | Filing → |
| BHVN | SELL | 2021-11-17 | $8.8M | — | Filing → |